We saw similar frequencies of CD4+ T-cell responses to all SARS-CoV-2 antigens, and these were highest in COVID-19 patients 1–3 months post symptom onset (means of ~3–4% of CD4+ T-cells), and were significantly higher than in individuals with other respiratory infections (Figure 1b). This evidence concerns the gene CD4 and respiratory tract infectious disorder.